Of possible interest

KEI objects to U.S. Army grant of exclusive license to Sanofi on U.S. Army-owned patents on Zika Virus vaccine.

The UN Secretary General High Level Panel on Access to Medicine. KEI submissions.

Request to NIH and Army to use government royalty free or march-in rights in the prostate cancer drug Xtandi.

Proposal for a WTO Agreement on the Supply of Public Goods.

Prices and patents on drugs, vaccines and diagnosis of hepatitis.

Innovation inducement prizes, possibly as an alternative to IPR monopolies to reward successful innovation.

Now is a good time to donate money to KEI

KEI Timelines, on a variety of topics.

Poll

Governments can ration access to cancer drugs, or break patent monopolies. Why is rationing so popular?:

EB130: CMC Churches' Action for Health intervention on the Consultative Expert Working Group on Research and Development (CEWG)

This was the statement delivered by CMC Churches' Action for Health intervention on 21 January 2012 on the Consultative Expert Working Group on Research and Development: Financing and Coordination at the 130th WHO Executive Board meeting.

CMC Churches' Action for Health intervention on the Consultative Expert Working Group on Research
and Development: Financing and Coordination at the 130th WHO Executive Board meeting

WHO 130th Executive Board Agenda Item 6.14

Intervention by James Love, CMC Churches' Action for Health

KEI files amicus brief in BRCA gene patent case

Since May 2009, the ACLU and Public Patent Foundation (PUBPAT) have been litigating a case involving the patent eligibility of two human genes, BRCA1 and BRCA2, associated with ovarian and breast cancer. ACLU and PUBPAT, representing the petitioners, Association for Molecular Pathology, among others, have argued that human genes are not patentable and that patents on such objects stifle diagnostic testing and further research.

KEI brown bag lunch with Shira Perlmutter, January 27, 2012

For call-in details for today's event, contact Krista Cox.

On January 27, 2012, KEI will host a brown bag lunch with Shira Perlmutter. Shira was recently appointed the Administrator for Policy and External Affairs of USPTO. This position was most recently held by Albert Tramposch, who replaced Arti Rai, the first Obama appointee.
perlmutter.jpg

WHO reform efforts to consider new modalities for engagement with NGOs, foundations, partnerships and for-profit-organizations

WHO reform is among the hot topics for consideration at the 130th session of the WHO Executive Board which meets from 16 January 2012 to 23 January 2012. One paper in particular, EB130/5 Add.4, entitled, "Governance: Promoting engagement with other stakeholders and involvement with and oversight of partnerships" describes how WHO may re-assess its relationship with non-governmental organizations including,

Response to Federal Register notice seeking comments regarding Canada's interest in TPPA negotiations

On December 7, 2011, USTR issued Federal Register Notice 76480-76481 requesting comments on "Canada's Expression of Interest in the Proposed Trans-Pacific Partnership Trade Agreement." USTR issued similar requests for comments regarding Japan's (Notice 76478-76479) and Mexico's (Notice 76479-76480) expression of interest in the TPPA.

KEI has submitted a response to this notice available for download here.

Article on medical innovation prize fund from Het Financieele Dagblad

Attached is a pdf of an article in the Dutch Het Financieele Dagblad, regarding medical innovation prize funds. An html version is available here.

Program of the 130th session of the WHO Executive Board (16 January 2012 - 23 January 2012)

World Health Organization

The 130th session of the WHO Executive Board will examine inter alia, the following technical items:

Prevention and control of noncommunicable diseases (scheduled for discussion on Thursday, 19 January 2012)

Representatives Issa (R-CA) and Maloney (D-NY) introduce anti-open access legislation

On December 16, 2011, H.R. 3699, "the Research Works Act", was introduced by Rep. Darrell Issa (R-CA), Chairman of the Committee on Oversight and Government Reform, and Committee member Rep. Carolyn Maloney (D-NY). This is how the Association of American Publishers describes the bill:

KEI comments for House Committee on Ways and Means Hearing on Trans-Pacific Partnership Agreement (TPPA)

On Wednesday, December 14, 2011 the Subcommittee on Trade of the Committee on Ways and Means held a hearing on the Trans-Pacific Partnership Agreement (TPPA). Oral testimony was accepted only from invited witnesses. These witnesses included: Ambassador Demetrios Marantis (Deputy U.S. Trade Representative), Devry S. Boughner (Director, Intenrational Business Relations on behalf of Cargill Inc. and U.S. Business Coalition for TPP), Angela Marshall Hofmann (Vice President for Global Integrated Sourcing on Trade, Wal-Mart Stores), and Michael Wessel (President of The Wessel Group).

USTR to "clarify" its position on extension of LDC transition period for TRIPS

On June 11, 2011, KEI published KEI Policy Brief 2011:1, which was titled: "White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs)."

16 December 2011: KEI side event @ 8th WTO Ministerial Conference: The TRIPS Agreement and Copyright

Friday, 16 December 2011
Knowledge Ecology International (KEI) side event @ 8th WTO Ministerial Conference
Geneva
Room B, Centre William Rappard, World Trade Organization
Rue de Lausanne 154
11:00 AM to 1:00 PM

The TRIPS Agreement and Copyright

Knowledge Ecology International
Introduction

TRIPS, the copyright 3-step test, and exceptions to rights

WIPO Standing Committee on the Law of Patents: Obama Administration's proposal on patents and health

On Wednesday, 7 December 2011, the United States of America tabled a proposal on patents and health which was distributed at 6 PM by the WIPO Secretariat after much of the substantive dicussions

Standing Committee on the Law of Patents

Seventeenth Session
Geneva, December 5 to 9, 2011

PATENTS AND HEALTH: PROPOSAL BY THE DELEGATION OF THE UNITED STATES OF AMERICA

Document prepared by the Secretariat

KEI's intervention to WIPO's Standing Committee on the Law of Patents (SCP)

Statement of Knowledge Ecology International (KEI) to the WIPO Standing Committee on the Law of Patents (SCP): Patents and Health

7 December 2011

Thank you Mr. Chair. Knowledge Ecology International has submitted its written comments on patents and health which can be found in WIPO document SCP/17/INF/3.

WIPO patent committee: Statement of Group B (industrialized countries) at WIPO on discussions of patents and health

The United States, on behalf of Group B (which includes Western European countries, Norway, the United States, Switzerland, Japan, Canada, New Zealand, Australia, Turkey, Israel and the Holy See) presented the following statement opposing the adoption of the African Group/Development Agenda Group on patents and health (in its current forum). In its individual intervention, the Holy See supported the African Group/Development Agenda Group proposal.

SCCR23: Statement by KEI on the protection of broadcasting organizations

With respect to broadcasting, KEI reiterates its opposition to work at WIPO on a new treaty for broadcasting organizations.

When governments grant intellectual property rights to broadcasting organizations, they undermine the rights of copyright holders, and reduce the incomes of creative communities.

Syndicate content